Ending All Respiratory Infections
6 hours ago
- #public-health
- #respiratory-infections
- #philanthropy
- Intercept is a $500 million philanthropic initiative aiming to eliminate respiratory infections like colds and flu.
- Respiratory infections cause significant health and economic burdens, including 15-25 sick days annually per healthy person, serious diseases, and ~$600B global productivity losses.
- Two main technologies are proposed: broad-spectrum preventatives (BSPs) like shots or pills, and air cleaning technologies (ACTs) like filtration and far-UVC light.
- Challenges include technical hurdles, underfunding, and lack of commercial incentives, but new scientific advances make solutions increasingly feasible.
- Intercept will fund grants and investments to advance BSPs to Phase 2 trials and generate real-world evidence for ACTs, supported by a Customer Advisory Board including major companies.
- The goal is to reduce the effective reproduction number (Re) of viruses below 1 through combined BSP and ACT deployment, potentially eliminating many respiratory infections.